YNBY International

YNBY International Limited, a subsidiary of the Yunnan Baiyao Group, serves as the international investment and operational platform for one of China's most prominent pharmaceutical brands. Headquartered in Hong Kong and listed on the HKEX, the company has transitioned from a diversified holding company into a specialized healthcare and logistics entity. Its core business segments include the trading of healthcare products, the development of industrial hemp and CBD-based wellness solutions, and money lending services. By leveraging the Yunnan Baiyao brand, YNBY International focuses on expanding the global footprint of Traditional Chinese Medicine (TCM) and botanical extracts. The company is actively building a vertically integrated supply chain for cannabinoid products, targeting international markets for skincare and health supplements.